Kotak Healthcare Fund Overview
Category Pharma Fund
BMSMONEY Rank N/A
Rating N/A
Growth Option 21-02-2025
NAV ₹12.18(R) -1.69% ₹12.43(D) -1.69%
Returns 1Y 3Y 5Y 7Y 10Y
Lumpsum Regular 6.69% -% -% -% -%
Direct 8.47% -% -% -% -%
Nifty Pharma TRI 8.49% 16.98% 20.4% 13.51% 6.47%
SIP (XIRR) Regular -3.18% -% -% -% -%
Direct -1.51% -% -% -% -%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
Top Pharma Fund
Fund Name Rank Rating
Sbi Healthcare Opportunities Fund -
Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund -
Tata India Pharma & Healthcare Fund -
Dsp Healthcare Fund -
Uti Healthcare Fund -
Nippon India Pharma Fund -
Mirae Asset Healthcare Fund -
Aditya Birla Sun Life Pharma & Healthcare Fund -

NAV Date: 21-02-2025

Scheme Name NAV Rupee Change Percent Change
Kotak Healthcare Fund - Regular Plan - Growth Option 12.18
-0.2100
-1.6900%
Kotak Healthcare Fund - Regular Plan - IDCW Option 12.19
-0.2100
-1.6900%
Kotak Healthcare Fund - Direct Plan - Growth Option 12.43
-0.2100
-1.6900%
Kotak Healthcare Fund - Direct Plan - IDCW Option 12.43
-0.2100
-1.6800%

Review Date: 21-02-2025

A review of the different performance parameters of the fund is as follows:
  1. Returns: It indicates the appreciation in the investment's value within the investment period, represented as a percentage or a specific amount of money. We conducted an analysis of the four return parameters of this fund to assess their performance. To assess performance, we have segmented the return parameters into three groups: the top 25%, parameters below the top 25% but still above average, and parameters below average. The results are provided below.
    1. Top 25%: The fund does not have any return parameter in the top 25% in the category.
    2. Above Average Below the Top 25%: The fund does not have any return parameter which is above average but below the top 25%.
    3. Below Average: Kotak Healthcare Fund has four return parameters that are below average in the category, which are listed below:
      • 1Y Return %
      • 6M Return %
      • 3M Return %
      • 1M Return %
  2. Risk: Various factors can lead to the risk of either not meeting expected returns or encountering a monetary loss. For Kotak Healthcare Fund, we have analyzed zero risk parameters and divided them into three groups the lowest 25%, below average but above the lowest 25%, and above average, which are described below.
    1. Lowest 25%: Kotak Healthcare Fund does not have any risk parameters in the lowest 25% of the category. It means high risk compared to other funds in the category.
    2. Below Average but Above the Lowest 25%: Kotak Healthcare Fund does not have any risk parameters in the below average but above the lowest 25% of the category.
    3. Above Average: Kotak Healthcare Fund does not have any risk parameters above average; which is a good sign.
  3. Risk Adjusted Performance Parameters: In mutual funds, risk-adjusted performance parameters are evaluation tools that gauge the returns of an investment against the risk taken. They assist investors in comparing various investments, factoring in both risk and returns. We have evaluated zero risk-adjusted performance parameters of the fund.
    1. Top 25% Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the top 25% of the category.
    2. Above Average Below Top 25% Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the above average but below top 25% of the category.
    3. Below Average Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the above average but below top 25% of the category.


Not able to see in mobile!!! save the chart by clicking on camera icon.

KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % -9.04 -6.64
-6.97
-9.04 | -5.72 13 | 13 Poor
3M Return % -8.58 -6.02
-6.79
-9.68 | -4.84 12 | 13 Average
6M Return % -7.42 -9.49
-6.24
-17.69 | -0.25 8 | 13 Good
1Y Return % 6.69 8.49
11.55
1.74 | 21.28 11 | 13 Average
1Y SIP Return % -3.18
1.08
-11.88 | 13.28 10 | 13 Average
Return data last Updated On : Feb. 21, 2025.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Jan. 31, 2025
KPIs: Key Performance Indicators

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % -8.93 -6.64 -6.87 -8.93 | -5.64 13 | 13
3M Return % -8.21 -6.02 -6.48 -9.30 | -4.55 12 | 13
6M Return % -6.65 -9.49 -5.62 -16.99 | 0.61 8 | 13
1Y Return % 8.47 8.49 13.01 3.43 | 22.79 10 | 13
1Y SIP Return % -1.51 2.46 -10.32 | 14.73 10 | 13
Return data last Updated On : Feb. 21, 2025.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Jan. 31, 2025
KPIs: Key Performance Indicators

Investment Period Regular Direct
Return % Current Value of ₹ 10000 Return % Current Value of ₹ 10000
1D -1.69 ₹ 9,831.00 -1.69 ₹ 9,831.00
1W -1.30 ₹ 9,870.00 -1.28 ₹ 9,872.00
1M -9.04 ₹ 9,096.00 -8.93 ₹ 9,107.00
3M -8.58 ₹ 9,142.00 -8.21 ₹ 9,179.00
6M -7.42 ₹ 9,258.00 -6.65 ₹ 9,335.00
1Y 6.69 ₹ 10,669.00 8.47 ₹ 10,847.00
3Y ₹ ₹
5Y ₹ ₹
7Y ₹ ₹
10Y ₹ ₹
15Y ₹ ₹

Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.

Investment Period Invested Amount Regular Direct
XIRR % Current Value of Invested Amount XIRR % Current Value of Invested Amount
1Y ₹ 12000 -3.18 ₹ 11,791.03 -1.51 ₹ 11,901.28
3Y ₹ 36000 ₹ ₹
5Y ₹ 60000 ₹ ₹
7Y ₹ 84000 ₹ ₹
10Y ₹ 120000 ₹ ₹
15Y ₹ 180000 ₹ ₹


Date Kotak Healthcare Fund NAV Regular Growth Kotak Healthcare Fund NAV Direct Growth
21-02-2025 12.184 12.429
20-02-2025 12.393 12.643
19-02-2025 12.333 12.581
18-02-2025 12.366 12.614
17-02-2025 12.426 12.674
14-02-2025 12.345 12.59
13-02-2025 12.701 12.952
12-02-2025 12.687 12.937
11-02-2025 12.725 12.976
10-02-2025 13.093 13.351
07-02-2025 13.416 13.678
06-02-2025 13.491 13.754
05-02-2025 13.461 13.723
04-02-2025 13.319 13.577
03-02-2025 13.135 13.389
31-01-2025 13.145 13.397
30-01-2025 13.081 13.332
29-01-2025 12.949 13.197
28-01-2025 12.646 12.887
27-01-2025 12.923 13.169
24-01-2025 13.241 13.492
23-01-2025 13.559 13.814
22-01-2025 13.371 13.623
21-01-2025 13.395 13.647

Fund Launch Date: 11/Dec/2023
Fund Category: Pharma Fund
Investment Objective: The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly Pharma, Healthcare, and allied sectors. However, there is no assurance that the objective of the scheme will be achieved.
Fund Description: An open ended equity scheme investing in Pharma, Healthcare & allied sectors.
Fund Benchmark: Nifty Healthcare Total Return Index
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.